Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy
Overview
The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.
Full Title of Study: “Incidence of Fluoroquinolone Resistant Enterobacteraciae in Patients Undergoing Repeat Ultrasound Guided Prostate Biopsy”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: June 2014
Arms, Groups and Cohorts
- Repeat Prostate Biopsy
- Men who undergo repeat prostate biopsy
Participating in This Clinical Trial
Inclusion Criteria
- adult males – repeat prostate biopsy Exclusion Criteria:
- first time prostate biopsy – minors
Gender Eligibility: Male
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of California, Irvine
- Collaborator
- Copan Diagnostics, Inc.
- Provider of Information About this Clinical Study
- Principal Investigator: Thomas E. Ahlering, MD – University of California, Irvine
- Overall Official(s)
- Atreya Dash, MD, Principal Investigator, University of California, Irvine
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.